Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Curcuminoids, particularly curcumin—the main active compound in turmeric—have been investigated for their potential antidepressant effects. Several preclinical studies in animal models have demonstrated that curcumin exhibits antidepressant-like activity, possibly by modulating neurotransmitter levels, reducing inflammation, and acting as an antioxidant. Human clinical trials are more limited in number and quality, but a few randomized controlled trials have reported that curcumin supplementation (often standardized extracts) may be beneficial as an adjunct to conventional antidepressant therapy or for mild to moderate depression. For instance, some studies have observed improvements in depressive symptoms compared to placebo, with proposed mechanisms involving modulation of monoaminergic neurotransmission (serotonin, dopamine, norepinephrine) and inhibition of inflammatory cytokines.

However, the evidence is not yet robust. Limitations include small sample sizes, short durations, variability in curcumin formulations and dosages, and inconsistencies in outcomes. Systematic reviews and meta-analyses suggest a possible positive effect, but stress the need for larger, high-quality clinical trials to confirm efficacy and optimal dosing. While curcumin has a long history of traditional use in Ayurvedic and traditional Chinese medicine, its specific use for depression is a more recent, science-driven development. Thus, while there is scientific interest and preliminary evidence supporting curcuminoids for depression, the current level of evidence is moderate and not definitive.

More about Curcuminoid (unspecified)
More about Depression

Other ingredients used for Depression

Other health conditions supported by Curcuminoid (unspecified)

Products containing Curcuminoid (unspecified)